Van Phan

[Dirk Smeets @dsmeets]

BREAKING NEWS. I am incredibly excited to announce the FDA clearance of icobrain aria, as the first and only cleared device for the detection, diagnosis, & monitoring of ARIA, a potentially harmful side effect of new amyloid-targeting therapies for Alzheimer's disease.

[icometrix @icometrix]

✨We're unveiling our #icobrain aria at #CTAD2023 revolutionizing #Alzheimer’s care! Our #AI solution enhances #ARIA detection, ensuring precise safety monitoring for patients on monoclonal antibody therapies. #futureofhealthcare #icometrix #CTAD2023 👉https://t.co/WG6bRtH8cO 🧠

[icometrix @icometrix]

Here's why Imapole Lyon-Villeurbanne has chosen #icobrain: How #radiologists use our #AI solution in clinical routine for all cognitive impairments assessments & their ROI, according to Dr. Beuret and Exec. Dir. Mr. Lounis https://t.co/4TBREzNy1z @GuerbetGroup

[icometrix @icometrix]

Chapter 1 of #ALZimaging is about the main underlying pathophysiological mechanisms of #AD and ways to assess them with #neuroimaging.
Completing this part will take about 20 minutes, after which you can test your knowledge in a quiz.
Register for free 👉 https://t.co/VSaVqmyqsf

[AppliedRadiology @Applied_Rad]

Get ready for new videos for https://t.co/xlwEw3WZIN, the e-learning platform that offers educational content on Alzheimer's disease and its relationship to neuroimaging. Learn More ⏩https://t.co/8wcOiUfakZ #NeuroImaging #NeuroRad #Neurology #RadRes #Alzheimers @suzie_bash

[icometrix @icometrix]

Chapter 5 of #ALZimaging is live! Completing this chapter will deepen your knowledge of Current and future #neuroimaging tools for #PatientMonitoring, as well as on features for tracking #DiseaseProgression.

Access the free platform here: https://t.co/VSaVqmyqsf

[icometrix @icometrix]

#wearehiring
We are looking for a Cloud Security Specialist to complete our team.
Read all about the opportunity to extend our #icometrix cloud infrastructure and data management, and apply via our webpage: https://t.co/bcS4LTK33z

[icometrix @icometrix]

Which neurodegenerative disease typically presents this altered FDG pattern? Test your knowledge on the free #alzimaging platform https://t.co/wXvqVV4doK

#weareicometrix #alzheimer #differentialdiagnosis #BrainAI #personalizedmedicine #MRI #measurablybetter

[icometrix @icometrix]

Missed the last episode of @TheASNR #Alzheimer’s series on ‘#Brain Health in the New Era’ presented by @cyrusraji , @ChelseaStillman and Meike Vernooij? Watch the webinar here https://t.co/cIPtvI12rp and get your #CME accreditation! #AD #ALZimaging #neuroradiology

[The American Society of Neuroradiology @TheASNR]

Join us Wednesday, December 15, at 4:00 pm EST for the fourth and final webinar in ASNR's #Alzheimer's Webinar Series: Brain Health in a New Era. Get all of the details and register now: https://t.co/YFAHrNZe8p
#neurorad #neuroradiology

[icometrix @icometrix]

Wednesday, Dec. 15, (3PM CT), @TheASNR will air the last episode of its #Alzheimer’s series. Tune in to hear @cyrusraji , @ChelseaStillman and Meike Vernooij on ‘Brain Health in the New Era’. (CME accredited).
Register here: https://t.co/iWqk6XcknG #ALZimaging #AD

[icometrix @icometrix]

Today @TheASNR kicks off its 3rd #AD webinar at 4PM EDT, focusing on #Amyloid & Tau #PET https://t.co/10aaWwON9c which ties-in nicely with #ALZimaging's 1st chapter 👉Beta-amyloid PET can be useful for differential diagnosis; want to find out more? https://t.co/VSaVqmyqsf

[icometrix @icometrix]

What do you know about side effects of anti-amyloid immunotherapies for #Alzheimer’s disease? Enhance your knowledge on #ARIA-E and ARIA-H; their #imaging spectrum & reporting, with newly added #safetyreading content on https://t.co/OcSq811rdY #AD #DM

[icometrix @icometrix]

We're kicking off #AAIC21 today! Drop by our booth #2320, or virtually https://t.co/z32vzWo7kl. Curious for your thoughts & feedback on our FDA-cleared diagnostic & monitoring #icobrain platform for #AD. #MeasurablyBetter #BrainAI #MRI
@alzassociation

[icometrix @icometrix]

CT and/or MRI are generally performed when neurodegenerative disease is suspected in people with mild cogn. impairment (#MCI) or #dementia. Can you diagnose #AD based on #brain atrophy? Check #ALZimaging & get up to speed on the neuroimaging modalities. https://t.co/OcSq811rdY

[icometrix @icometrix]

Today's #aducanumab FDA approval reinforces the importance of having a clear understanding & continued education of #Alzheimers. #ALZimaging offers content on #AD & its relationship with neuroimaging techniques for diagnosis, management, and safety reading https://t.co/OcSq811rdY

[icometrix @icometrix]

#MRI in dementia & #AD: why does a timely #AD diagnosis matter? Why the need for sensitive & specific metrics? Join our webinar on Quantitative #MRI analysis in #AD 30/03; discuss diff. diagnosis & predictive modeling. Register now👉https://t.co/nSyGM5IJfd @Gertjan8 @SEngelborghs

[icometrix @icometrix]

#JobAlert Ready to transform patient care through impactful #AI imaging? #WeAreHiring! Actively looking for a Project Manager Clinical Trials #ApplyNow & grow together with us. View all our vacancies: https://t.co/bcS4LTK33z #WeAreicometrix #crazitivity #RadAI #BrainAI

[Maaike Vandermosten @VandermostenM]

Congratulations Dr @tvanphan! An online defense is not evident but you did great. Your expertise now stretches the continuum from pediatric MRI method development to the neural basis of dyslexia. What a wonderful journey it has been together with @icometrix and @ChildBrainITN

[icometrix @icometrix]

Did you miss our amazing webinar on pediatric image processing with @JoelTalcott, @DrBrainbow, and @tvanphan? Rewatch it here: https://t.co/TSa49Z619g #ChildBrain #MR #icobrain @ChildBrainITN